UNCOVERING THE BENEFITS OF THE ACCU- CHEK BOLUS ADVISOR MICHAEL PORTER CDE

Size: px
Start display at page:

Download "UNCOVERING THE BENEFITS OF THE ACCU- CHEK BOLUS ADVISOR MICHAEL PORTER CDE"

Transcription

1 UNCOVERING THE BENEFITS OF THE ACCU- CHEK BOLUS ADVISOR MICHAEL PORTER CDE 1

2 LEARNING OBJECTIVES By the end of this session participants should be able to understand: The benefits of bolus advisors The physiological rationale for the settings within the Accu-Chek Bolus Advisor The way the Accu-Chek Bolus Advisor corrects to mid target and handles active insulin The effects of changes in the bolus advice parameters The bolus delivery alterations available to cover various health events The key differences between the Accu-Chek Bolus Advisor and other bolus advice systems

3 Part 1: Part 2: Part 3: Part 4: Part 5: Part 6: Part 7: Part 8: Part 9: Mealtime Insulin and Bolus Advisors Meeting the new ISO standard for BGL accuracy A Wide Range of Programmable Parameters The Effects of Changing Parameters Correcting to Target Handling of Active Insulin Health Events Putting it all Together Accu-Chek Bolus Advice Simulator Workshop OUTLINE

4 Mealtime rise and post-meal hyperglycaemia Post-meal hyperglycaemia is a risk factor for: Macrovascular disease (heart attack, stroke ) Microvascular disease (retinopathy, nephropathy ) Cancer Impaired cognitive function in the elderly A meal rise of greater than 2.8mmol/L is associated with increased development of atherosclerosis 1. Slama et al. 2006, Diabetes Metab 32: Esposito et al 2008, J Clin Endo Metab 93(4):

5 Rapid-acting insulin Manufacturers product information NovoRapid Humalog Apidra Rapid-acting insulins Novo Nordisk Eli Lilly Sanofi Max effect: 1-3 hr Max effect: minutes Max effect: 55 minutes Duration of effect: 3-5 hr Duration of effect: 4 hr Duration of effect: 4 hr Maximum effect, BG starts to fall again = Offset time (1hr) Duration of effect = Acting time (4hr) References: Respective companies product information leaflets

6 Complexity of bolus calculations Everyone is different Calculations need to take into account: Current BGL Target BGL Amount of carbs to be eaten Insulin sensitivity (reduction of BGL per unit of insulin) Insulin to carb ratio Individual, situation-specific influencing factors (i.e. sport, illness, active insulin etc.)

7 Benefits of bolus advisors Reduce barriers to bolusing and improve compliance 1 Reduce number of calculation mistakes 1 Improve metabolic control 1 Less need for correction boluses or supplementary snacks respectively 2 Pre-programming allows for alternative care givers to deliver care 3 1. Glaser NS et al. J Pediatr Endocrinol Metab Gross TM et al. Diabetes Technol Ther ISPAD. Paediatric Diabetes 2007:8;88-102

8 ABACUS study 1 Participants and design Randomised 218 patients who had received carb counting training, and were on flexible daily insulin therapy Prospective, randomized, multi-center, controlled study of ~26 weeks duration Control group: Manually calculated insulin dose using on BGL and CHO intake, based on their healthcare professional s guidance Intervention group: Used the Accu-Chek Bolus Advisor, in consultation with their healthcare professional Published in Diabetes Care, Ziegler R. et al. 2013, Diabetes Care 36:

9 Achieved >0.5% HbA1c reduction ABACUS study Improved glycaemic control Patients achieving >0.5% HbA1c reduction 80% 60% 40% 20% 0% 34.4% n=32 p<0.01 Control (n=93) 56.0% n=56 In participants with poorly controlled diabetes, 63% more intervention patients achieved an HbA1c reduction of >0.5% than control participants All completers 1. Ziegler R. et al. 2013, Diabetes Care 36:

10 Achieved >0.5% HbA1c reduction ABACUS study HbA1c reduction in younger people Patients aged yrs achieving >0.5% HbA1c reduction 80% 60% 40% 20% 0% 15.0% p< % Younger participants showed particular benefit from the Accu-Chek Bolus Advisor: 3.5 times as many achieved the goal HbA1c reduction vs. control Control Accu-Chek Bolus Advisor Completers aged years* * Patient numbers not provided for this metric 1. Ziegler R. et al. 2013, Diabetes Care 36:

11 ABACUS study No increase in severe hypoglycaemia Use of the Accu-Chek Bolus Advisor was associated with: No significant increase in frequency of severe hypoglycaemia (bg <2.8 mmol/l) Significantly greater improvements in treatment satisfaction 1. Ziegler R. et al. 2013, Diabetes Care 36:

12 Bolus advisors Not all bolus advisors are equal All available bolus advisors offer similar basic characteristics: Consideration of active insulin or insulin on board Acting time setting Different bolus options Carbohydrate input Correction bolus advice Hyper/hypo warnings

13 Bolus advisors Not all bolus advisors are equal Essential differences between the Accu-Chek Bolus Advisor and other systems include: Independent certification of accuracy at the new ISO standard 1 A wide range of programmable parameters Correction to target range Handling of active insulin Consideration of health events 1. Data on file

14 Appropriate insulin dosing requires accurate BGLs Bolus calculators rely on an accurate BGL to calculate an appropriate insulin dose According to the old ISO standard, manufacturers only needed to deliver accuracy within 20% of the true BGL For a BGL of 9 mmol/l, this would mean a reading would only need to fall between 7.2 and 10.8 mmol/l This could have a significant impact on the insulin dose recommended

15 Appropriate insulin dosing requires accurate BGLs All Accu-Chek meters meet the new ISO 15197:2013 guidelines for accuracy in diabetes management, according to independent assessments 1 Independent local studies support the accuracy and precision of Accu-Chek strips, 2, 3 for example: Adapted from Roser et al, Data on file 2. Roser M et al., St Vincents Hospital, Sydney. Presented at AACB Annual Scientific Meeting, Oct Kitchener L & Freitas G, Liverpool Hospital, Sydney. Presented at AACB Annual Scientific Meeting, Sep 2008

16 A wide range of programmable parameters The Accu-Chek Bolus Advisor has additional programmable parameters to better simulate rapidacting insulin action Meal rise Offset time Snack size This enables patients and HCPs to adjust the bolus advice settings to their individual needs and, most importantly, better manage post-meal BGLs

17 Blood glucose level (mmol/l) Meal rise (2.8 mmol/l) Insulin acting time (hours) The Accu-Chek Bolus Advisor Overview Offset time Length of time after a bolus until a reduction in BG begins Meal rise Expected rise in BGLs in response to a meal 8.8 Offset time (1 hr) Acting time Total length of time the insulin is expected to be lowering BG Target range Normal time course of insulin action Acting time (4 hr) Accu-Chek Bolus Algorithm Allowable BG range while insulin is acting Correction Bolus Calculation Out of range BGLs during the acting time trigger corrections

18 Blood glucose level (mmol/l) Meal rise (2.8 mmol/l) The Accu-Chek Bolus Advisor Step by Step Offset time Length of time after a bolus until a reduction in BG begins Meal rise Expected rise in BGLs in response to a meal 8.8 Offset time (1 hr) Acting time Total length of time the insulin is expected to be lowering BG Target range Normal time course of insulin action Acting time (4 hr) Accu-Chek Bolus Algorithm Allowable BG range while insulin is acting Correction Bolus Calculation Out of range BGLs during the acting time trigger corrections Insulin acting time (hours)

19 Blood glucose level (mmol/l) Insulin acting time (hours) The Accu-Chek snack size function Meals vs snacks Meal Snack Physiologically, there is a minimal rise in the BGL expected after a snack compared to a meal

20 The Accu-Chek snack size function Definition Every carb intake entered into Bolus Advisor will trigger calculation However, the activation of the Meal Rise feature for the a depends on the Snack Size parameter (set between 0 24g c The Snack Size setting defines a certain threshold above w Meal Rise bg pattern is triggered When a user enters carbs that are within the Snack Size se a bolus is calculated but the Meal Rise is not triggered For example: If Snack Size setting = 15g One biscuit is eaten, in this case = 12g

21 The Accu-Chek Bolus Advisor Allows for adjustments with snacks The snack size function: Prompts a meal-centric dose to cover small amounts o For carbs within the Snack Size setting, a meal-rise is no allowing high BGLs between meals to be addressed With a meal rise Without a meal rise od glucose level (mmol/l) Pre-meal level Meal Snack Insulin acting time (hours) These high post-meal BGLs will no receive a correction recommend

22 Without snack size functionality bg level FREQUENT MEALS COULD CAUSE A CONSTANT MEAL RISE ELEVATED BGLS WOULD BE CONSTANTLY ALLOWED NO RECOMMENDATION SUGGESTED POORER CONTROL AND HIGHER HBA1C

23 Blood glucose level (mmol/l) The Accu-Chek Bolus Advisor Allows for adjustments with snacks The snack size function: Prompts a meal-centric dose to cover small amounts For carbs within the Snack Size setting, a meal-rise is n allowing high BGLs between meals to be addressed Meal Snack Meal Snack Meal Insulin acting time (hours)

24 Blood glucose level (mmol/l) The Accu-Chek Bolus Advisor Allows for adjustments with snacks The snack size function: Prompts a meal-centric dose to cover small amounts For carbs within the Snack Size setting, a meal-rise is n allowing high BGLs between meals to be addressed Without a snack size funct this high BGL would have b left unaddressed due to th larger allowable range Meal Snack Meal Snack Meal Insulin acting time (hours)

25 The Accu-Chek Bolus Advisor Allows for adjustments with snacks So if Mary is only eating a small amount Snack size allows the user to designate an amount of carbs above which a meal rise will be triggered* This is extremely useful for frequent eaters, such as children More than this meal rise * A meal bolus will still be recommended to cover the carbs Less than this no meal rise

26 Blood glucose level (mmol/l) Meal rise (2.8 mmol/l) The Accu-Chek Bolus Advisor Offset time Length of time after a bolus until a reduction in BG begins Meal rise Expected rise in BGLs in response to a meal Target range Offset time (1 hr) Normal time course of insulin action Acting time (4 hr) Snack eaten No meal rise 4 Acting time Total length of time the insulin is expected to be lowering BG Accu-Chek Bolus Algorithm Allowable BG range while insulin is acting Correction Bolus Calculation Out of range BGLs during the acting time trigger corrections Snack Size Eating more than this amount of carbs will trigger a meal rise Insulin acting time (hours)

27 The Accu-Chek Bolus Advisor The Accu-Chek Bolus Advisor allows a wide range of parameter settings, increasing your ability to personalise healthcare: Acting time: 1:30 to 8:00 hours Offset time: 0:45 to 7:45 hours Meal BG rise: 2.8 to 11.1 mmol/l Snack size: 0 to 24 g

28 Blood glucose level (mmol/l) The Accu-Chek Bolus Advisor Adjusting acting time With shorter acting time, bolus recommendations may be higher. If acting time is too short it may increase the risk of excess insulin and of hypos With longer acting times, bolus recommendations are more moderate Insulin acting time (hours)

29 Blood glucose level (mmol/l) The Accu-Chek Bolus Advisor Adjusting offset time With shorter offset time*, bolus recommendations may be higher With longer offset times, bolus recommendations are more moderate Insulin acting time (hours) *For added safety, minimum offset time is 45 minutes

30 Blood glucose level (mmol/l) The Accu-Chek Bolus Advisor Adjusting meal rise With lower meal rise, bolus recommendations may be higher With higher meal rise, bolus recommendations are more moderate Insulin acting time (hours)

31 The Accu-Chek Bolus Advisor Adjusting snack size Allows users to determine their level of control in managing BGLs For tighter control the snack size may be set at the highest level (24 grams) Some users prefer to avoid potential insulin stacking over-correction caused by the first bolus after the snack (and potential hypoglycaemia) - so may set the snack size to 0 grams

32 The Accu-Chek Bolus Advisor Overview of parameter adjustments Expanding the allowable range (trapezoid) up or right allows higher BGLs, and moderates the recommendations Shrinking the allowable range (trapezoid) down or left leads to higher insulin dose recommendations Looser control Tighter control

33 Blood glucose targets Upper and lower targets can be specified BG targets for the Accu-Chek Bolus Advisor are calculated as the mid-point between the upper and lower limits If an individual s target range is 4-8 mmol/l, the mid-point will be 6 mmol/l Upper Limit Lower Limit Middle of target range

34 Why treat to the middle of the target range? Tighter control in response to high BGLs Return to a more normal BGL in response to low BGLs

35 Accu-Chek bolus advice Correction to middle of target range No mealtime insulin dose required Mealtime insulin dose required No correction Middle of target range

36 Corrections when not taking mealtime insulin Accu-Chek Medtronic Animas Insulinx 8 No correction No correction No correction 4 As there is no mealtime insulin dose being taken, the Accu Bolus Advisor does not recommend an extra injection/ e unless BGLs are above the target range

37 Corrections when taking meal insulin Accu-Chek Medtronic Animas Insulinx 8 No correction No correction 4 The Accu-Chek Bolus Advisor offers the tightest correc recommendations, to optimise high and low BGLs

38 Insulin (units) Correcting to target Better glycaemic control with Accu- Chek Accu-Chek Medtronic Animas Correction dose Meal dose Mealtime bolus dose recommendations with pre-prandial BGL = 9.7 mmol/l: All bolus advisors recommended 5.3 units to cover carbs ( ) Accu-Chek and Animas systems recommended a correction dose of 1.3 units; the Medtronic system only suggested 0.6 units ( ) 1. McDaniel, A, et al. 2nd Intl Conference on Advanced Technologies & Treatments for Diabetes, A237, 2009

39 HANDLING OF ACTIVE INSULIN Two distinct targets for BG control For people with Type 1 Diabetes, treatment needs to: 1. Provide insulin to store mealtime glucose: Mealtime or meal-centric insulin Only maintains the pre-meal BGL 2. Provide insulin to correct high BGLs: Correction or glucose-centric insulin Will not address mealtime carbs Reduces BGL These are addressing different issues with the person s diabetes and shouldn t be merged together

40 Putting it together Mary is high and hungry Mary s carb ratio is 1:15 and her ISF is 1: 3 Mary is about to eat 60g of carbs, and her BGL is 12 mmol/l. How much insulin should she have with her meal? To cover the carbs? To bring BGL down to 6? Mary s total dose? 4 Meal-centric 2 Glucose-centric (Correction/Active Insul Total = 6 units of insulin

41 Active insulin and other bolus advisors Most bolus calculators will recommend meal and correction doses at mealtime However, only the Accu-Chek Bolus Advisor keeps meal and glucose-centric insulin separate in its memory for later bolus calculations Accu-Chek Other bolus advisors 4 Meal-centric: To address carb intake 6 Active insulin or insulin on board 2 Glucose-centric or active insulin: To address high BGLs

42 * Insulinx allows single target or target range to be selected Active insulin and other bolus advisors The Accu-Chek system recognises that there is a smaller amount of insulin available to lower BGLs Accu-Chek 2 Glucose-centric or active insulin Medtronic 6 Animas Insulinx* Active insulin, or insulin on board 6 Active insulin, or insulin on bo Higher probability of correction! Lower probability of correction! Lower probability of correction! The Accu-Chek Bolus Advisor is more likely to recommen correction doses than other bolus advisors

43 Insulin (units) Handling of active insulin Tighter post-meal control with Accu-Chek Correction recommended Accu-Chek Medtronic Animas * Animas 2020 and Medtronic Paradigm bolus calculators 2-hour postprandial bolus recommendations, for BGL of 13.7 mmol/l: Other systems* overestimated the active insulin ( ) The Accu-Chek Bolus Advisor was the only system to recommend correction insulin to address postprandial hyperglycaemia 2 hours after the meal ( ) 1. McDaniel, A, et al., 2009, 2nd Intl Conference on Advanced Technologies & Treatments for Diabetes, A237

44 Meals Handling of active insulin Tighter post-meal control with Accu-Chek 1 Number of correction boluses recommended at 2 hr n= n= Accu-Chek Medtronic 72 meals 69 meals The Accu-Chek Bolus Advisor recommended more correction boluses at 2 hrs post-meal than the Medtronic Paradigm bolus wizard, with more BGLs returning to target at 6 hours This was achieved without an increase in hypoglycaemia 1. Zisser H, et al. Diabetes Technol Ther. 2010; 12(12):

45 Health events No two days are the same A number of different circumstances can affect insulin needs on a day-to-day basis, such as: Sickness Exercise Stress Being pre-menstrual In the past, people had to guess how to account for these variations when estimating insulin

46 Consideration of health events The Accu-Chek Bolus Advisor is the only system that incorporates Health Events : Exercise 2 programmable event fields to allow for different exercise regimens Stress Illness Premenstrual Helps adjust bolus advice to individual needs Helps people understand and remember factors that they should consider with their bolus delivery!

47 The Accu-Chek Bolus Advisor Health events settings to support bolus advice Exercise increases insulin sensitivity Health Events allow you to account for lower insulin needs around exercise Other life factors may increase insulin needs (Stress, Illness, Premenstrual status)

48 Blood glucose level (mmol/l) Meal rise (2.8 mmol/l) Insulin acting time (hours) IN SUMMARY The Accu-Chek Bolus Advisor Offset time Length of time after a bolus until a reduction in BG begins Meal rise Expected rise in BGLs in response to a meal Target range Offset time (1 hr) Normal time course of insulin action Acting time (4 hr) Snack eaten No meal rise 4 Acting time Total length of time the insulin is expected to be lowering BG Accu-Chek Bolus Algorithm Allowable BG range while insulin is acting Correction Bolus Calculation Out of range BGLs during the acting time trigger corrections Snack Size Eating more than this amount of carbs will trigger a meal rise

49 1. Check bgl Simple, discreet delivery of recommended bolus doses 3. Deliver Insulin Blood glucose Active insulin Enter carbs Health 2. Enter Carbs and any adjustments Correction Meal insulin insulin Health Bolus adjustment

50 1. Data on file The Accu-Chek Bolus Advisor Summary of advantages 1. Independent certification of accuracy - at the new ISO standard 1 2. Corrects to midpoint of target range - provides bolus recommendations for better control 3. Only correction insulin is treated as active - ability to recommend higher corrections when required 4. Offers a wider range of programmable parameters - meal rise, offset time and snack size to better fit individual needs 5. Offers additional parameter of health events - offers quick customisation to changing daily circumstances

51 The Accu-Chek Bolus Advisor Evidence-based insulin management The Accu-Chek Bolus Advisor is used in both the Accu- Chek Combo insulin pump system and the Accu-Chek Aviva Expert meter Peer-reviewed research confirms the value of the Accu- Chek Bolus Advisor: 1. Ziegler R. et al. 2013, Diabetes Care 36: 3613

52 Questions?

53 Presentation endorsed by ADEA for 2 CPD Points.

Blood glucose Meter Roche USA V6/ PMS 287 Proof Print Number 209 Advanced Owner s Booklet

Blood glucose Meter Roche USA V6/ PMS 287 Proof Print Number 209 Advanced Owner s Booklet This file may not print or view at 100%. Die lines and color breaks do not print. Roche USA 50841 V6/1 06434258002 Black Proof Print Number 209 06434258002-0512 Roche USA 50841 V6/2 06434258002 Cyan Proof

More information

Pump Failure Guidelines

Pump Failure Guidelines Pump Failure Guidelines Planning Ahead All technology, including pumps, can fail occasionally, even within their warranty period. It is important to be able to independently initiate injection treatment

More information

WOULD YOU LIKE TO REDUCE THE FEAR OF HYPOGLYCAEMIA FOR YOUR PATIENTS?

WOULD YOU LIKE TO REDUCE THE FEAR OF HYPOGLYCAEMIA FOR YOUR PATIENTS? WOULD YOU LIKE TO REDUCE THE FEAR OF HYPOGLYCAEMIA FOR YOUR PATIENTS? THE ONLY SYSTEM CLINICALLY PROVEN TO REDUCE HYPOGLYCAEMIA MINIMED 640G SYSTEM WITH SMARTGUARD TECHNOLOGY 1 HYPOGLYCAEMIA IS CHALLENGING

More information

THE ONLY SYSTEM^ CLINICALLY PROVEN TO REDUCE HYPOGLYCAEMIA

THE ONLY SYSTEM^ CLINICALLY PROVEN TO REDUCE HYPOGLYCAEMIA THE ONLY SYSTEM^ CLINICALLY PROVEN TO REDUCE HYPOGLYCAEMIA MINIMED 640G system^ with SmartGuard technology HYPOGLYCAEMIA IS CHALLENGING FOR GLYCAEMIC CONTROL 1 AND quality of life 2 Achieving good glucose

More information

TYPE 1 DIABETES AND EXERCISE. Mark W Savage

TYPE 1 DIABETES AND EXERCISE. Mark W Savage TYPE 1 DIABETES AND EXERCISE Mark W Savage Acknowledgments Slides with a blue background are cropped and courtesy of both Eli Lilly and Company, and Dr Ian Gallen FRCP Consultant Diabetologist, Royal Berkshire

More information

Performance-powered. The OneTouch. Ping insulin pump and meter-remote.

Performance-powered. The OneTouch. Ping insulin pump and meter-remote. Performance-powered. The OneTouch Ping insulin pump and meter-remote. I We don t just deliver insulin. We deliver outstanding clinical performance. P36337_OTP_DetAid_OmniPodUpdate_r12.indd 1 OneTouch Ping.

More information

Insulin Pumps Available in Canada

Insulin Pumps Available in Canada Insulin Pumps Available in Canada A Comparison from WaltzingTheDragon.ca *Accu-Chek Animas Ping/Vibe Medtronic Minimed 630G Omnipod ABOUT FORM: Is the insulin pump Tubing- Free? Is the pump? Or Water-Resistant?

More information

Designed with your patients lives in mind

Designed with your patients lives in mind The Accu-Chek Insight diabetes therapy system Designed with your patients lives in mind With pre-filled insulin cartridge Designed for easy patient training The Accu-Chek Insight diabetes therapy system

More information

University College Hospital. Blood glucose and HbA 1 c targets

University College Hospital. Blood glucose and HbA 1 c targets University College Hospital Blood glucose and HbA 1 c targets Children & Young People s Diabetes Service The diabetes team at UCLH aims to help every child and young person with Type 1 Diabetes to safely

More information

How I use the latest technology to investigate and treat a person with Type 1 Diabetes. Dr Pratik Choudhary

How I use the latest technology to investigate and treat a person with Type 1 Diabetes. Dr Pratik Choudhary How I use the latest technology to investigate and treat a person with Type 1 Diabetes Dr Pratik Choudhary Disclosures Advisory board and speaker fees from Medtronic, Roche, Abbott and Johnson and Johnson,

More information

24 Hour Support. Telephone Available 24 hours a day, 7 days a week

24 Hour Support. Telephone Available 24 hours a day, 7 days a week Contents Page What is SHAIRE? 1 What is basal-bolus regimen? 2 Why do I need a basal-bolus regimen? 3 How does basal insulin work? 3 How does rapid-acting insulin work? 4 How often should I test my Blood

More information

Using the Bolus Wizard Calculator

Using the Bolus Wizard Calculator 9501179-011 Using the Bolus Wizard Calculator Objective Describe the features and benefits of the Bolus Wizard Calculator Key Points The Bolus Wizard: Estimates high blood glucose corrections using the

More information

Walsall CCG Supported Blood Glucose Meters April 2018

Walsall CCG Supported Blood Glucose Meters April 2018 Meter Name Picture Type Strips Lancets Information Company PRIMARY CARE INITIATION TEE2+ Uncomplicated Type 2 diabetes patient on TEE2 test CareSens Lancets Easy to use. Large clear display Bluetooth functionality

More information

The Realities of Technology in Type 1 Diabetes

The Realities of Technology in Type 1 Diabetes The Realities of Technology in Type 1 Diabetes May 6, 2017 Rosanna Fiallo-scharer, MD Margaret Frederick, RN Disclosures I have no conflicts of interest to disclose I will discuss some unapproved treatments

More information

Case Study: Competitive exercise

Case Study: Competitive exercise Case Study: Competitive exercise 32 year-old cyclist Type 1 diabetes since age 15 Last HbA1 54 No complications and hypo aware On Humalog 8/8/8 and Levemir 15 Complains about significant hypoglycaemia

More information

Understanding the CareLink TM Therapy Management Dashboard Report

Understanding the CareLink TM Therapy Management Dashboard Report 3 2 1 5 6 7 4 1 This is a great place to start recognizing trends. In this example you may see plenty of events that result in a low glucose trend. A low glucose is identified as a value less than 70mg/dL.

More information

University College Hospital. Exercise and Activity Management Multiple Daily Injections

University College Hospital. Exercise and Activity Management Multiple Daily Injections University College Hospital Exercise and Activity Management Multiple Daily Injections Childrens and Young People s Diabetes Service Being active is an important part of a healthy lifestyle. Being more

More information

Counting the Carbs, Fat and Protein in Type 1 Diabetes Translating the Research into Clinical Practice

Counting the Carbs, Fat and Protein in Type 1 Diabetes Translating the Research into Clinical Practice Welcome to Allied Health Telehealth Virtual Education Counting the Carbs, Fats and Protein in Type 1 Diabetes Translating the Research into Clinical Practice Dr Carmel Smart, PhD Senior Specialist Paediatric

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Review of TA151 Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus This guidance was issued in

More information

WHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES?

WHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES? Christian In better control with his pump since 2012 WHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES? Many people with Type 1 diabetes worry about potential long-term

More information

PROTOCOL FOR HYBRID CLOSED LOOP TECHNOLOGY

PROTOCOL FOR HYBRID CLOSED LOOP TECHNOLOGY PROTOCOL FOR HYBRID CLOSED LOOP TECHNOLOGY Situations Requiring Special Consideration and Resource Documents Second Edition MiniMed 67G System Medical Education TABLE OF CONTENTS A PROTOCOL FOR HYBRID

More information

Diabetes Newly Diagnosed with NO evidence of DKA

Diabetes Newly Diagnosed with NO evidence of DKA 1. DIAGNOSIS confirmed by doctor using below guidelines: (a) History of Polyuria (usually nocturia ± enuresis) Polydipsia. ± Weight Loss (b) Glycosuria (c) Blood Glucose (BG) > 11 mmol/l (confirm from

More information

CARELINK PERSONAL ACTIONABLE INSIGHTS FOR BETTER DIABETES MANAGEMENT CARELINK REPORTS GUIDE

CARELINK PERSONAL ACTIONABLE INSIGHTS FOR BETTER DIABETES MANAGEMENT CARELINK REPORTS GUIDE CARELINK PERSONAL ACTIONABLE INSIGHTS FOR BETTER DIABETES MANAGEMENT CARELINK REPORTS GUIDE CARELINK PERSONAL ACTIONABLE INSIGHTS FOR BETTER DIABETES MANAGEMENT As part of your diabetes therapy you have

More information

WOULD YOU LIKE MORE CONFIDENCE IN YOUR HYPOGLYCAEMIC CONTROL? SMARTGUARD. PROVIDES PREDICTIVE PROTECTION

WOULD YOU LIKE MORE CONFIDENCE IN YOUR HYPOGLYCAEMIC CONTROL? SMARTGUARD. PROVIDES PREDICTIVE PROTECTION WOULD YOU LIKE MORE CONFIDENCE IN YOUR HYPOGLYCAEMIC CONTROL? SMARTGUARD. PROVIDES PREDICTIVE PROTECTION 1,2 MINIMED 640G WITH SMARTGUARD HAVE YOU CONSIDERED THE REAL IMPACT HYPOGLYCAEMIA HAS ON YOUR LIFE?

More information

2016 Diabetes Management Plan

2016 Diabetes Management Plan Early childhood education and care setting 2016 Diabetes Management Plan Insulin pump therapy [to be used in conjunction with Action Plan] Name of child: Date of birth: Name of centre: Age : This plan

More information

Diabetes Management App. Instruction Manual

Diabetes Management App. Instruction Manual Diabetes Management App Instruction Manual Accu-Chek Connect Diabetes Management App Overview The Accu-Chek Connect diabetes management app (hereafter referred to as the app) is designed to help you: Transfer

More information

Guide to Flexible Insulin Therapy for Families

Guide to Flexible Insulin Therapy for Families Guide to Flexible Insulin Therapy for Families Purpose of Guide This guide is for people with type one diabetes on flexible insulin therapy. The purpose of this information is to explain flexible insulin

More information

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS) DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS) Type 2 Diabetes Clinical Guideline Self-monitoring of blood glucose (SMBG) should be considered but not routinely offered for adults with type 2 diabetes

More information

Advances in Diabetes Care Technologies

Advances in Diabetes Care Technologies 1979 Advances in Diabetes Care Technologies 2015 Introduction Insulin pump use: ~ 20% - 30% of patients with T1DM < 1% of insulin-treated patients with T2DM 2007 FDA estimates ~375,000 insulin pumps for

More information

Type 1 Diabetes & Continuous Glucose Monitoring. Dr Sheila Cook Director of Diabetes & Endocrinology Toowoomba Hospital

Type 1 Diabetes & Continuous Glucose Monitoring. Dr Sheila Cook Director of Diabetes & Endocrinology Toowoomba Hospital Type 1 Diabetes & Continuous Glucose Monitoring Dr Sheila Cook Director of Diabetes & Endocrinology Toowoomba Hospital Let s consider the traditional diabetes clinic The Diabetes Clinic Whenever I check

More information

MINIMED 640G WITH SMARTGUARD GIVES YOU CONFIDENCE TO TAKE CONTROL OF YOUR DIABETES

MINIMED 640G WITH SMARTGUARD GIVES YOU CONFIDENCE TO TAKE CONTROL OF YOUR DIABETES MINIMED 640G WITH SMARTGUARD GIVES YOU CONFIDENCE OF YOUR DIABETES HAVE YOU CONSIDERED THE REAL IMPACT HYPOS HAVE ON YOUR LIFE? AN ESTIMATED 1 HOUR EVERY DAY IS LOST TO THE MANAGEMENT OF 43% OF PEOPLE

More information

2016 Diabetes Management Plan for school Insulin pump therapy [to be used in conjunction with Action Plan]

2016 Diabetes Management Plan for school Insulin pump therapy [to be used in conjunction with Action Plan] 2016 Diabetes Management Plan for school Insulin pump therapy [to be used in conjunction with Action Plan] Name of student: Date of birth: Name of school: Grade/Year : Insulin pump model: This plan should

More information

2. Evidence of continued professional development in this area on a 2 yearly basis

2. Evidence of continued professional development in this area on a 2 yearly basis Nutrition and Physical Activity Diabetes Competencies briefing document from the Diabetes Education and management Group (DMEG) and Diabetes UK - May 2013 The Quality and Outcomes Framework (QOF) requirement

More information

University College Hospital. Managing meals high in protein and/or fat a guide for Omnipod pump users

University College Hospital. Managing meals high in protein and/or fat a guide for Omnipod pump users University College Hospital Managing meals high in protein and/or fat a guide for Omnipod pump users Children and Young people s diabetes service This information is based on the research and experience

More information

Continuous Glucose Monitoring (CGM) Dexcom G6 Training for Healthcare Professionals and Patients

Continuous Glucose Monitoring (CGM) Dexcom G6 Training for Healthcare Professionals and Patients ssociation of Children s Diabetes Continuous Glucose Monitoring (CGM) Dexcom G6 Training for Healthcare Professionals and Patients 1 ssociation of Children s Diabetes Contents Chapter Page no. Chapter

More information

Presented by Dr. Bruce Perkins, MD MPH Dr. Michael Riddell, PhD

Presented by Dr. Bruce Perkins, MD MPH Dr. Michael Riddell, PhD Type 1 Diabetes and Exercise: Optimizing the Medtronic MiniMed Veo Insulin Pump and Continuous Glucose Monitoring (CGM) for Better Glucose Control 1,2 for Healthcare Professionals Presented by Dr. Bruce

More information

DIABETES MANAGEMENT PLAN 2017

DIABETES MANAGEMENT PLAN 2017 EARLY CHILDHOOD EDUCATION AND CARE SETTING Insulin pump therapy Use in conjunction with Action Plan DIABETES MANAGEMENT PLAN 2017 Name of child: Name of centre: of birth: Age: This plan should be reviewed

More information

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) SETTING FOR STAFF PATIENTS Medical and nursing staff Children and young

More information

Diabetes Management: Current High Tech Innovations

Diabetes Management: Current High Tech Innovations Diabetes Management: Current High Tech Innovations How Far We ve Come in the Last 40 Years William V. Tamborlane, MD Department of Pediatrics Yale School of Medicine Disclosures I am a consultant for:

More information

Fine-tuning of The Dose of Insulin Pump

Fine-tuning of The Dose of Insulin Pump Fine-tuning of The Dose of Insulin Pump The manual does not guarantee specific individual or specific applicability of the environment, there is no express or implied warranties. Contents of this manual

More information

Aviva Combo BLOOD GLUCOSE METER. Advanced Owner s Booklet for Self-Testing Only

Aviva Combo BLOOD GLUCOSE METER. Advanced Owner s Booklet for Self-Testing Only Aviva Combo BLOOD GLUCOSE METER Advanced Owner s Booklet for Self-Testing Only Before You Start Testing About the meter and test strips Carefully read and follow the instructions in the Getting Started

More information

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS) Type 2 Diabetes DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS) Clinical Guideline Self-monitoring of blood glucose (SMBG) should be considered but not be routinely offered for adults with type 2 diabetes

More information

Insulin Pump Therapy. WakeMed Children s Endocrinology & Diabetes WakeMed Health & Hospitals Version 1.3, rev 5/21/13 MP

Insulin Pump Therapy. WakeMed Children s Endocrinology & Diabetes WakeMed Health & Hospitals Version 1.3, rev 5/21/13 MP Insulin Pump Therapy WakeMed Children s Endocrinology & Diabetes Overview What is an insulin pump? What are the advantages and disadvantages of an insulin pump? Lifestyle Changes Food Management Exercise

More information

EAST OF ENGLAND CHILDREN AND YOUNG PEOPLE S DIABETES NETWORK. Optimising Glycaemic Control for Children and Young People with Diabetes

EAST OF ENGLAND CHILDREN AND YOUNG PEOPLE S DIABETES NETWORK. Optimising Glycaemic Control for Children and Young People with Diabetes EAST OF ENGLAND CHILDREN AND YOUNG PEOPLE S DIABETES NETWORK Optimising Glycaemic Control for Children and Young People with Diabetes Local diabetes teams need to take on the responsibility of ensuring

More information

ssociation of Children s Diabetes Clinicians Clinicians Continuous Glucose Monitoring (CGM) Training for Healthcare Professionals and Patients

ssociation of Children s Diabetes Clinicians Clinicians Continuous Glucose Monitoring (CGM) Training for Healthcare Professionals and Patients ssociation of Children s Diabetes Continuous Glucose Monitoring (CGM) Training for Healthcare Professionals and Patients 1 ssociation of Children s Diabetes Contents Chapter Page no. STEP 1...3 Getting

More information

The York Diabetes Care Model

The York Diabetes Care Model This Session The York Diabetes Care Model The annual review what s it for and how to do it How to make the diagnosis of diabetes and who to test Categorisation of diabetes at diagnosis Basics of Insulin

More information

Initiation of insulin adjustment for carbohydrate at onset of diabetes in children using a home-based education programme with a bolus calculator

Initiation of insulin adjustment for carbohydrate at onset of diabetes in children using a home-based education programme with a bolus calculator Initiation of insulin adjustment for carbohydrate at onset of diabetes in children using a home-based education programme with a bolus calculator H Thom 1 BSc (Hons), Paediatric Diabetes Dietitian S Greene

More information

The principles of insulin adjustment guidance

The principles of insulin adjustment guidance The principles of insulin adjustment guidance Tips for insulin titration Blood glucose (BG) monitoring is needed to help identify the efficacy of treatment in diabetes. Monitor blood glucose according

More information

Diabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE

Diabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE Diabetes and Technology Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE Disclosure Speaker s Bureau: Janssan Pharmaceuticals Current Technology V-Go by Valeritas Continuous Sensors (personal

More information

Glucometers Gastrostomy Tubes Nasogastric Tubes Insulin pumps Continuous Glucose monitoring system Closed Loop Smart phones/tablets

Glucometers Gastrostomy Tubes Nasogastric Tubes Insulin pumps Continuous Glucose monitoring system Closed Loop Smart phones/tablets Devices Glucometers Gastrostomy Tubes Nasogastric Tubes Insulin pumps Continuous Glucose monitoring system Closed Loop Smart phones/tablets Accuracy Glucometers The ISO (International Organization for

More information

Advances in Diabetes Care Technologies

Advances in Diabetes Care Technologies 1979 Advances in Diabetes Care Technologies 2015 Introduction Roughly 20% - 30% of patients with T1DM and fewer than 1% of insulin-treated patients with T2DM use an insulin pump In 2007, the US FDA estimated

More information

RELEASED. first steps. Icon Icon name What it means

RELEASED. first steps. Icon Icon name What it means Icon Icon name What it means Connection The connection icon appears green when the Sensor feature is on and your transmitter is successfully communicating with your pump. The connection icon appears gray

More information

International Journal of Scientific & Engineering Research Volume 8, Issue 5, May ISSN

International Journal of Scientific & Engineering Research Volume 8, Issue 5, May ISSN International Journal of Scientific & Engineering Research Volume 8, Issue 5, May-2017 58 SMARTPHONE BASED INSULIN RECOMMENDATION FOR TYPE1 DIABETES 1 Keerthanaa R, 2 Dr. K. Kumar 1 PG Scholar, 2 Assistant

More information

Understanding the CareLinkTM Sensor Meter Overview Report: Page 1

Understanding the CareLinkTM Sensor Meter Overview Report: Page 1 Understanding the CareLinkTM Sensor Meter Overview Report: Page 1 Sensor & Meter Overview (1 of 3) 4-Hour Glucose Sensor Overlay - Readings & Averages (mg/dl) 1 Glucose Sensor Overlay Bedtime to Wake-Up

More information

Report Reference Guide

Report Reference Guide Report Reference Guide How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used to generate the sample reports was from sample patient

More information

DAFNE (Dose Adjustment For Normal Eating)

DAFNE (Dose Adjustment For Normal Eating) DAFNE (Dose Adjustment For Normal Eating) Promoting the Expert Patient Professor David McIntyre Mater Health Services and University of Queensland Brisbane AUSTRALIA DAFNE and OzDAFNE Outline Context of

More information

Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes

Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes Introduction Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes This guideline is designed to offer guidance for primary and secondary care on the use of selfmonitoring of blood glucose

More information

Interpreting the charts & graphs

Interpreting the charts & graphs Report reference guide mg/dl The diasend solution Interpreting the charts & graphs diasend is a universal cloud-based diabetes data management system, that enables you to upload data from meters, pumps

More information

Diabetes Skills. Tips to help you keep your Blood Glucose in range. Food. Hypos. Data and Targets. Exercise

Diabetes Skills. Tips to help you keep your Blood Glucose in range. Food. Hypos. Data and Targets. Exercise Diabetes Skills Tips to help you keep your Blood Glucose in range Food Hypos Exercise Data and Targets Targets: HbA1c NICE (2015) recommendation 48mmol/mol ( 6.5%) As close to this target as is possible

More information

CareLink. software REPORT REFERENCE GUIDE. Management Software for Diabetes

CareLink. software REPORT REFERENCE GUIDE. Management Software for Diabetes CareLink Management Software for Diabetes software REPORT REFERENCE GUIDE How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used

More information

REPORT INTERPRETATION

REPORT INTERPRETATION REPORT INTERPRETATION: Interpreting ipro Professional Continuous Glucose Monitoring (CGM) Reports and Making Therapy Adjustments TARGET AUDIENCE The audience for this section is physicians, mid-level practitioners,

More information

Monitoring in Type 2 Diabetes. Learning Outcomes. Type 2 Diabetes. Senga Hunter Community Diabetes Specialist Nurse

Monitoring in Type 2 Diabetes. Learning Outcomes. Type 2 Diabetes. Senga Hunter Community Diabetes Specialist Nurse Monitoring in Type 2 Diabetes Senga Hunter Community Diabetes Specialist Nurse Learning Outcomes Understand why blood monitoring is necessary Understand the blood tests for monitoring diabetes Understand

More information

See the Using RapidCalc section for a description of the controls and operation of the calculator.

See the Using RapidCalc section for a description of the controls and operation of the calculator. Introduction Welcome to RapidCalc, a quick interactive tool to help you calculate Rapid Acting Insulin (RAI) doses, record Basal insulin doses and manage your blood glucose (BG) levels. Before RapidCalc

More information

Technology for Diabetes: 101 Basic Rules of the Road. Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE

Technology for Diabetes: 101 Basic Rules of the Road. Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE Technology for Diabetes: 101 Basic Rules of the Road Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE Quick Pump Facts! o Constant insulin supply o Pager-sized mini-computer worn

More information

15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016

15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016 15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016 Sponsored by: Abbott Diabetes Care and Lilly Diabetes Type 1 and exercise Royal Berkshire Hospital Centre for Diabetes and Endocrinology

More information

Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond)

Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond) Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond) 9501366-011 20110401 Objectives Understand the need for insulin pumps and CGMS in managing

More information

DIABETES MANAGEMENT PLAN 2017

DIABETES MANAGEMENT PLAN 2017 SCHOOL SETTING Insulin pump therapy Use in conjunction with Action Plan DIABETES MANAGEMENT PLAN 2017 Name of student: Name of school: Date of birth: Grade/Year: Insulin pump model: This plan should be

More information

15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016

15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016 15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016 Sponsored by: Abbott Diabetes Care and Lilly Diabetes The REPOSE Trial (Relative Effectiveness of Pumps over Structured Education) Background

More information

Emerging Automated Insulin Delivery Systems

Emerging Automated Insulin Delivery Systems Emerging Automated Insulin Delivery Systems Richard M. Bergenstal, MD International Diabetes Center Park Nicollet & HealthPartners Minneapolis, MN Presenter Name 1 Dualities: Richard M. Bergenstal, MD

More information

GLOOKO DREAMED FOR ANDROID USER GUIDE

GLOOKO DREAMED FOR ANDROID USER GUIDE GLOOKO DREAMED FOR ANDROID USER GUIDE November 2018 IFU-0017 02 TABLE OF CONTENTS TABLE OF CONTENTS GENERAL INFORMATION... 2 Product Description... 2 Glooko Intended Use... 2 Dreamed Intended Use... 2

More information

Resources relevant for 6 7 year olds

Resources relevant for 6 7 year olds Resources relevant for 6 7 year olds Guide for healthcare professionals This guide outlines the goals of diabetes education for your 6 7 year old patients. Use this guide as part of a narrative discussion

More information

Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus

Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus Version No. Changes Made Version of July 2018 V0.5 Changes made to the policy following patient engagement including: - the

More information

MANAGING MEALTIME INSULIN

MANAGING MEALTIME INSULIN MEDICATION MANAGING MEALTIME INSULIN kk WHY IS THIS LEAFLET FOR YOU? The blood glucose level in someone who does not have diabetes keeps remarkably steady despite variable meal sizes and amount of activity.

More information

Aviva Combo BLOOD GLUCOSE METER. Getting Started Guide for Self-Testing Only

Aviva Combo BLOOD GLUCOSE METER. Getting Started Guide for Self-Testing Only Aviva Combo BLOOD GLUCOSE METER Getting Started Guide for Self-Testing Only Before You Start Testing About the meter and test strips Carefully read and follow the instructions in the Getting Started Guide,

More information

FBC, HbA1c, U/E, FT4, Blood Gas, Thyroid antibodies, TSH, Coeliac screen, GAD antibodies, Islet cell antibodies, and insulin antibodies.

FBC, HbA1c, U/E, FT4, Blood Gas, Thyroid antibodies, TSH, Coeliac screen, GAD antibodies, Islet cell antibodies, and insulin antibodies. 1. DIAGNOSIS confirmed by doctor using below guidelines: (a) History of polyuria (usually nocturia ± enuresis) Polydipsia ± weight loss (b) Glycosuria (c) Blood Glucose (BG) > 11 mmol/l (confirm from a

More information

How they work and when to take them. Diabetes Medications

How they work and when to take them. Diabetes Medications How they work and when to take them Diabetes Medications BIGUANIDES Metformin Actions Slows down the release of glucose from the liver. Helps the bodies cells become more sensitive to insulin. Pros Weight

More information

DIABETES STRUCTURED EDUCATION IN WORCESTERSHIRE Information for Healthcare Professionals May 2011

DIABETES STRUCTURED EDUCATION IN WORCESTERSHIRE Information for Healthcare Professionals May 2011 DIABETES STRUCTURED EDUCATION IN WORCESTERSHIRE Information for Healthcare Professionals May 2011 What is Structured Education? Diabetes Structured Education is referred to in the Diabetes NSF standards

More information

Insulin Pump Therapy

Insulin Pump Therapy Patient and Family Education Insulin Pump Therapy The insulin pump is a device that gives insulin to the body at a steady rate. With the pump you won t need daily shots. This handout describes how insulin

More information

National Best Practice Guides: Inpatients on Continuous Subcutaneous Insulin Infusion (CSII)

National Best Practice Guides: Inpatients on Continuous Subcutaneous Insulin Infusion (CSII) Gold Sponsors: Silver Sponsors: National Best Practice Guides: Inpatients on Continuous Subcutaneous Insulin Infusion (CSII) #abcdipn17 @uk_ipn Bronze Sponsors: The sponsoring pharmaceutical companies

More information

Resources relevant for year olds

Resources relevant for year olds Resources relevant for 14 15 year olds Guide for healthcare professionals This guide outlines the goals of diabetes education for your 14 15 year old patients. Use this guide as part of a narrative discussion

More information

Managing your diabetes: Travel Advice

Managing your diabetes: Travel Advice Managing your diabetes: Travel Advice Information for patients, relatives and carers For more information, please contact: Your diabetes team on telephone number 01904 726510 The York Hospital Wigginton

More information

SFHDiabPT03 Provide dietary education for an individual with Type 1 diabetes who is contemplating insulin pump therapy

SFHDiabPT03 Provide dietary education for an individual with Type 1 diabetes who is contemplating insulin pump therapy Provide dietary education for an individual with Type 1 diabetes who is contemplating insulin pump therapy Overview This standard concerns the activities of helping an individual with diabetes understand

More information

Insulin Prior Authorization Criteria For Individuals who Purchased BlueCare / KS Solutions products

Insulin Prior Authorization Criteria For Individuals who Purchased BlueCare / KS Solutions products Insulin Prior Authorization Criteria For Individuals who Purchased BlueCare / KS Solutions products FDA LABELED INDICATIONS 1-13,16-20 Rapid-Acting Indication Onset Peak Duration Insulins Fiasp (insulin

More information

MORE TIME TO BE. The MiniMed 670G system. Less time thinking about managing your diabetes. *1 More time focusing on your day. 2,3

MORE TIME TO BE. The MiniMed 670G system. Less time thinking about managing your diabetes. *1 More time focusing on your day. 2,3 MORE TIME TO BE Leanne. MiniMed TM 670G Ambassador The MiniMed 670G system Less time thinking about managing your diabetes. *1 More time focusing on your day. 2,3 *Some user interaction required. THE SYSTEM

More information

Insulin glulisine (Apidra) for type 1 diabetes mellitus in adolescents and children

Insulin glulisine (Apidra) for type 1 diabetes mellitus in adolescents and children Insulin glulisine (Apidra) for type 1 diabetes mellitus in adolescents and children December 2008 This technology summary is based on information available at the time of research and a limited literature

More information

Initiating Injectables in Type 2 Diabetes. Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital

Initiating Injectables in Type 2 Diabetes. Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital Initiating Injectables in Type 2 Diabetes Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital Increasing levels in delivery of diabetes care Complex Care support 3 3.1 People with diabetes

More information

Better connected for better decisions

Better connected for better decisions Introducing the Accu-Chek Connect diabetes management system Better connected for better decisions Help your patients use the power of their mobile devices and the web to manage their diabetes How many

More information

Insulin Pumps and Paediatrics

Insulin Pumps and Paediatrics Insulin Pumps and Paediatrics RURAL MATTERS Gippsland Acute Care Symposium Friday 27 th November 2015 Andrea Curtis, BN, Grad Cert Diabetes Education, CDE, CPT I wish (my friends) knew what it felt like

More information

Report Reference Guide. THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1

Report Reference Guide. THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1 Report Reference Guide THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1 How to use this guide Each type of CareLink report and its components are described in the following sections.

More information

Approach to the Young child & Parent with Child with DM Best Structure for Continued Care

Approach to the Young child & Parent with Child with DM Best Structure for Continued Care Approach to the Young child & Parent with Child with DM Best Structure for Continued Care M.S. Limbe MD Paediatric Endcocrinologist Aga Khan University Hospital, Nairobi Approach to the Young Child & Parent

More information

Insulin Prior Authorization Criteria For Individuals Who Purchased BlueCare/KS Solutions/EPO Products

Insulin Prior Authorization Criteria For Individuals Who Purchased BlueCare/KS Solutions/EPO Products Insulin Prior Authorization Criteria For Individuals Who Purchased BlueCare/KS Solutions/EPO Products FDA LABELED INDICATIONS 1-13,16-21 Rapid-Acting Indication Onset Peak Duration Insulins Admelog (insulin

More information

Information leaflet for MDI patients. Improving Diabetes using Diasend

Information leaflet for MDI patients. Improving Diabetes using Diasend Information leaflet for MDI patients Improving Diabetes using Diasend Contents Easy Steps for Setting up Diasend Account 2 Finding the resources on the internet 3 VIP Patient Diasend Assessment Template

More information

Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes

Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes Introduction Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes This guideline is designed to offer guidance for primary and secondary care on the use of selfmonitoring of blood glucose

More information

Essential advice for people with diabetes from Accu-Chek. Time to test. G1812 Time to Test leaflet v5.indd 1 25/02/ :43

Essential advice for people with diabetes from Accu-Chek. Time to test. G1812 Time to Test leaflet v5.indd 1 25/02/ :43 Essential advice for people with diabetes from Accu-Chek Time to test G1812 Time to Test leaflet v5.indd 1 25/02/2016 16:43 Why do I need to check m Going for a jog, drinks after work, eating out or a

More information

THERAPY MANAGEMENT SOFTWARE FOR DIABETES

THERAPY MANAGEMENT SOFTWARE FOR DIABETES THERAPY MANAGEMENT SOFTWARE FOR DIABETES Report Report Interpretation Reference Guide Guide 2009 Medtronic MiniMed. All rights reserved. 6025274-012_a CareLink Pro Report Reference Guide 0 p.2 Adherence

More information

This certificate-level program is non-sponsored.

This certificate-level program is non-sponsored. Program Name: Diabetes Education : A Comprehensive Review Module 5 Intensive Insulin Therapy Planning Committee: Michael Boivin, B. Pharm. Johanne Fortier, BSc.Sc, BPh.LPh, CDE Carlene Oleksyn, B.S.P.

More information

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Goulburn Region Preschool Association Inc.

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Goulburn Region Preschool Association Inc. DIABETES POLICY Mandatory Quality Area 2 The content of this policy was developed for KPV by advocacy and diabetes educators at Diabetes Australia Vic and the Royal Children s Hospital Melbourne s manager

More information

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Auburn South Preschool.

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Auburn South Preschool. DIABETES POLICY Mandatory Quality Area 2 The content of this policy was developed for ELAA by advocacy and diabetes educators at Diabetes Australia Vic and the Royal Children s Hospital Melbourne s manager

More information